- Home
- KYMR vs QRVO Comparison
KYMR vs QRVO Comparison
Compare KYMR & QRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KYMR | QRVO |
|---|---|---|
| Founded | 2015 | 1957 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.8B | 8.1B |
| IPO Year | 2020 | 2014 |
Fundamental Metrics
Financial Performance| Metric | KYMR | QRVO |
|---|---|---|
| Price | $80.62 | $78.10 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 26 | 12 |
| Target Price | ★ $107.72 | $90.55 |
| AVG Volume (30 Days) | 627.8K | ★ 1.0M |
| Earning Date | 05-18-2026 | 04-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 180.56 |
| EPS | N/A | ★ 3.30 |
| Revenue | $39,211,000.00 | ★ $3,718,971,000.00 |
| Revenue This Year | $16.05 | $0.81 |
| Revenue Next Year | $4.79 | N/A |
| P/E Ratio | ★ N/A | $23.67 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $19.45 | $49.46 |
| 52 Week High | $103.00 | $106.29 |
Technical Indicators
Market Signals| Indicator | KYMR | QRVO |
|---|---|---|
| Relative Strength Index (RSI) | 47.12 | 37.23 |
| Support Level | $77.78 | $75.57 |
| Resistance Level | $95.90 | $79.13 |
| Average True Range (ATR) | 4.42 | 1.84 |
| MACD | -1.27 | -0.22 |
| Stochastic Oscillator | 23.04 | 30.84 |
Price Performance
Historical ComparisonAbout KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.
About QRVO Qorvo Inc.
Qorvo represents the combined entity of RF Micro Devices and TriQuint Semiconductor, which merged in January 2015. The company specializes in radio frequency filters, power amplifiers, and front-end modules used in many of the world's most advanced smartphones. Qorvo also has a suite of products sold into a variety of nonsmartphone end markets, such as wireless base stations, cable TV and networking equipment, and infrastructure and military applications.